EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antiviral effects and mechanism of Qi pi pill against influenza viruses

Chengcheng Zhang iD, Jing Gao, Meiyue Dong, Carolina Q Sacramento, Ping Li, Xiangyu Lian, Lingyuan Fan, Lijun Rong, Ruikun Du, Jingzhen Tian, Qinghua Cui

Animal Models and Experimental Medicine · 2025

DOI: 10.1002/ame2.12511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Chengcheng Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Antiviral Agents, Drugs, Chinese Herbal, Orthomyxoviridae Infections, Influenza A virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Special Emergency research and development of Social Benefiting Technology Program, Qingdao, Project for Development of TCM Science and Technology of Shandong Province, Major Basic Program of Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Qi pi pill (QPP), which contains Renshen, Baizhu, Fuling, Gancao, Chenpi, Shanyao, Lianzi, Shanzha, Liushenqu, Maiya, and Zexie, was recommended for preventing and treating COVID‐19 in Shandong Province (China). However, the mechanism by which QPP treats infectious diseases remains unclear. This study aims to investigate the therapeutic effect of QPP in vitro and on acute influenza infection in mice, exploring its mechanism of action against influenza A virus (IAV).

Methods

The in vitro activity of QPP was assessed using dose–response curve analysis and titer reduction assay, and its antiviral mechanism was identified in vitro by real‐time polymerase chain reaction (PCR), time‐of‐addition, and enzymatic assays. The antiviral efficacy of QPP was further evaluated in vivo using BALB/c mice infected with IAV. At the same time, each single Chinese herbal medicine in QPP was evaluated to preliminarily identify those with antiviral effects.

Results

In vitro results showed that QPP exhibited a higher potency antiviral effect against both influenza A and B viruses, inhibiting viral RNA replication and release by targeting RNA‐dependent RNA polymerase and neuraminidase. Additionally, QPP significantly decreased the expression of inflammatory cytokines in A549 cells. In vivo study revealed that QPP significantly reduced the lung index and viral load in lung tissue of mice infected with IAV. Renshen, Gancao, Zexie, and Lianzi were the Chinese herbal medicines from QPP that showed anti‐IAV activity.

Conclusion

The antiviral activity of QPP targets IAV replication and release, cytokine modulation in host cells, and provides protection in mice with acute influenza infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsDrugs, Chinese HerbalOrthomyxoviridae InfectionsInfluenza A virusAnimalsMice, Inbred BALB CMiceHumansDogsVirus ReplicationFemaleMadin Darby Canine Kidney Cells

Stichwörter der Autor:innen

Chinese patent medicineQi pi pillanti‐inflammatoryinfluenza A virustraditional Chinese medicine

Substanzen

Antiviral AgentsDrugs, Chinese Herbal

Autor:innen und Institutionen

  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • The Third People's Hospital of Qingdao, Qingdao, Shandong, China.
  • Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China.
  • Qingdao Academy of Chinese Medicinal Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, Shandong, China.

ORCID-Profile: Chengcheng Zhang

Förderung

  • Special Emergency research and development of Social Benefiting Technology Program, Qingdao
  • Project for Development of TCM Science and Technology of Shandong Province
  • Major Basic Program of Natural Science Foundation of Shandong Province
  • Jinan City Funding for University Innovation Teams

Zitieren

APA

Zhang, C., Gao, J., Dong, M., Sacramento, C. Q., Li, P., Lian, X., Fan, L., Rong, L., Du, R., Tian, J., & Cui, Q. (2025). Antiviral effects and mechanism of Qi pi pill against influenza viruses. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12511

Vancouver

Zhang C, Gao J, Dong M, Sacramento CQ, Li P, Lian X, et al. Antiviral effects and mechanism of Qi pi pill against influenza viruses. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12511

BibTeX
@article{Zhang2025,
  author = {Zhang, Chengcheng and Gao, Jing and Dong, Meiyue and Sacramento, Carolina Q and Li, Ping and Lian, Xiangyu and Fan, Lingyuan and Rong, Lijun and Du, Ruikun and Tian, Jingzhen and Cui, Qinghua},
  title = {Antiviral effects and mechanism of Qi pi pill against influenza viruses},
  journal = {Animal Models and Experimental Medicine},
  year = {2025},
  doi = {10.1002/ame2.12511}
}
Kostenlos starten →